LifeMD, Inc.

LFMD Healthcare Health Information Services

LifeMD, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $194.1 million, up 25.3% from fiscal 2024. In the quarter to June 2026, revenue fell 3.55%, EPS fell 166.7% and free cash flow fell 247.5%, each against the same quarter a year earlier. Revenue growth for five consecutive years.

2.34 0.12 −4.88%
Market cap
$118.6M
P/E
0.0×
Fwd P/E
−17.9×
Dividend yield
—
F-score
6/9
Altman Z
−0.02
Beneish M
−3.67
Dividend safety
n/a
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
P/E ratio
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 13.12
Piotroski F-Score
3 5 5 3 3 4 5 6 4 6
Altman Z-Score
(11.47) 1.51 (3.65) (5.54) (16.03) (2.58) (11.19) 0.01 (2.04) (0.02)
P/S ratio
1.53 4.08 0.74 0.48 2.50 1.13 0.49 1.87 1.32 0.79
P/FCF ratio
0.00 0.00 0.00 23.62 0.00 0.00 0.00 3,289.06 21.91 0.00
Altman Z″-Score (non-manufacturers)
(53.34) (30.40) (18.90) (23.93) (49.29) (12.55) (40.94) (12.62) (13.47) (9.85)
P/Operating CF
(27.13) (29.96) (14.86) 37.37 (14.26) (17.94) (29.73) 50.02 189.99 (46.91)
Beneish M-Score
(4.98) (5.27) (4.39) (8.02) (15.84) (3.83) (3.73) (4.04) (4.06) (3.67)
P/B ratio
0.00 24.13 7.55 0.00 0.00 4.81 0.00 51.35 0.00 6.65
Price to Tangible BV
0.00 24.13 0.00 0.00 0.00 4.82 0.00 111.79 0.00 6.72
EV/Sales
1.52 4.07 0.73 0.46 2.28 0.70 0.49 1.78 1.22 0.68
EV/EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EV/Operating CF
(19.50) (18.34) (6.70) 22.58 (7.01) (1.97) (2.56) 30.81 10.83 16.01
EV/FCF
(19.50) (18.34) (6.70) 22.58 (6.76) (1.78) (1.64) 3,127.18 20.37 (106.73)
Quick Ratio
0.55 0.42 0.23 0.30 0.73 1.85 0.22 1.10 0.64 1.11
Current Ratio
0.69 1.97 1.35 0.69 0.89 1.97 0.36 1.22 0.78 1.25
Net Debt/EBITDA
0.07 (0.02) (0.04) 0.14 0.14 0.77 (0.01) 2.01 1.04 289.88
Debt/Assets
12.66% 13.25% 9.46% 24.51% 7.94% 3.70% 16.08% 30.66% 24.09% 0.00%
Debt/Equity
(0.28) 0.27 0.30 (0.75) (1.30) 0.07 (0.56) 3.22 (2.43) 0.00
Asset Turnover
8.46 3.59 4.29 4.11 4.43 2.93 3.15 3.63 2.30 2.65
Operating CF/Net income
0.37 0.68 0.73 (0.08) 0.19 0.54 0.47 (0.37) (0.71) 0.74
Capex/Depreciation
0.00 0.00 (0.20) 0.00 (0.33) (1.15) (1.02) (1.26) (1.24) (1.26)
Interest Coverage
(24.17) (12.22) (5.80) (3.80) (34.67) (17.98) (34.05) (5.58) (9.38) (5.64)
ROE
1,225.79% (923.78%) (172.03%) 2,027.27% 2,260.22% (716.97%) (988.99%) 751.79% 2,465.96% 144.18%
ROA
(178.87%) (117.45%) (63.96%) (103.50%) (752.12%) (195.08%) (128.70%) (56.34%) (36.43%) 15.35%
ROIC
0.00% (118.32%) (144.88%) 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Tangible Assets
306.19% (193.64%) (300.65%) 260.41% 5,088.17% (276.62%) 248.35% (285.61%) 180.38% 88.55%
Average Days of Receivables
31.14 12.71 4.35 2.85 9.77 3.85 8.69 12.63 24.65 17.50
Research and Development Expense of Revenue
0.00% 0.00% 1.45% 1.79% 1.20% 1.02% 2.50% 3.97% 4.43% 3.79%
Selling, General and Administrative Expense of Revenue
85.27% 105.72% 88.51% 90.75% 225.27% 131.44% 105.29% 84.00% 82.71% 74.21%
Intangible Assets out of Total Assets
0.00 0.00 0.39 0.20 0.03 0.00 0.15 0.05 0.00 0.00
Share Based Compensation of Revenue
11.22% 27.21% 8.48% 6.01% 99.11% 13.00% 12.22% 8.54% 7.90% 5.41%
Graham Net Nets
(0.04) 0.04 (0.03) (0.31) (0.02) 0.20 (0.37) (0.04) (0.15) 0.03
Graham Number
0.45 0.00 0.00 0.94 5.80 0.00 3.68 0.00 1.49 1.73
Earnings Yield
(13.82%) (8.82%) (25.34%) (57.47%) (72.89%) (58.66%) (83.07%) (8.30%) (10.91%) 7.62%
Free Cash Flow Yield
(5.08%) (5.44%) (14.64%) 4.23% (13.51%) (34.89%) (61.20%) 0.03% 4.56% (0.81%)
Revenue per Share
0.78 0.44 0.94 1.26 2.61 3.44 3.84 4.50 3.76 4.30
Operating CF per Share
(0.06) (0.10) (0.10) 0.03 (0.85) (1.22) (0.74) 0.26 0.43 0.18
Capex per Share
0.00 0.00 (0.01) 0.00 (0.03) (0.13) (0.42) (0.26) (0.20) (0.21)
Free Cash Flow per Share
(0.06) (0.10) (0.11) 0.03 (0.88) (1.35) (1.16) 0.00 0.23 (0.03)
Cash per Share
0.03 0.02 0.02 0.11 0.64 1.53 0.13 0.98 0.79 0.82
Shareholders Equity per Share
(0.05) 0.07 0.09 (0.11) (0.06) 0.96 (0.24) 0.16 (0.18) 0.51
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
(0.05) 0.07 0.09 (0.11) (0.06) 0.96 (0.24) 0.16 (0.18) 0.51
Free Cash Flow
(0.41) (0.82) (1.01) 0.25 (12.53) (36.49) (35.83) 0.09 9.31 (1.24)
Working Capital
(0.36) 0.62 0.41 (1.23) (1.52) 22.10 (20.06) 7.82 (15.03) 10.26
Capital Expenditures
— — (0.10) — (0.40) (3.40) (12.89) (8.73) (8.21) (9.52)
Net Current Asset Value
(0.36) 0.62 (0.19) (1.83) (1.81) 20.82 (21.66) (10.31) (31.28) 4.58
EV/EBIT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Capex to Sales
0.00 0.00 0.01 0.00 0.01 0.04 0.11 0.06 0.05 0.05
Price to Operating Income
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other line items
Depreciation/Fixed assets
0.00 0.00 0.00 40.59 4.43 12.66 26.52 14.56 4.58 3.09
Cash ROIC
515.68% (87.71%) (80.62%) 30.58% (132.99%) (52.88%) (4,588.69%) 0.15% 21.43% (2.07%)
Accounts Receivable Turnover
17.42 12.80 73.24 126.91 68.10 93.91 62.40 37.61 19.68 19.64
Accounts Payable Turnover
4.23 1.73 3.09 1.29 1.17 1.70 1.95 1.78 1.95 2.21
Inventory Turnover
17.58 2.42 2.34 2.56 8.00 12.49 7.02 5.85 7.72 9.95
Average Days of Payables
141.21 151.43 158.89 441.01 500.20 183.75 197.61 214.07 185.64 186.34
Days of Inventory on Hand
30.07 244.30 186.98 137.32 52.08 32.79 72.41 53.30 47.62 36.53
Average Receivables
0.30 0.29 0.11 0.10 0.55 0.99 1.91 4.06 7.87 9.88
Average Payables
0.46 0.59 0.65 1.96 7.60 10.60 9.58 10.60 10.99 12.53
Average Inventory
0.11 0.42 0.85 0.99 1.11 1.44 2.66 3.23 2.78 2.79
Average Assets
0.62 1.03 1.94 3.03 8.42 31.66 37.79 42.07 67.29 73.25
Average Common Equity
(0.09) 0.13 0.72 (0.15) (2.80) 8.62 4.92 (3.15) (0.99) 7.80

Fold the line items

Columns are period end dates